Ainos (AIMD) Competitors $0.46 +0.00 (+0.48%) (As of 12:38 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends AIMD vs. AWH, KZIA, SLGL, PMCB, NLSP, INAB, AVTX, CERO, TRIB, and BIORShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Aspira Women's Health (AWH), Kazia Therapeutics (KZIA), Sol-Gel Technologies (SLGL), PharmaCyte Biotech (PMCB), NLS Pharmaceutics (NLSP), IN8bio (INAB), Avalo Therapeutics (AVTX), CERo Therapeutics (CERO), Trinity Biotech (TRIB), and Biora Therapeutics (BIOR). These companies are all part of the "pharmaceutical products" industry. Ainos vs. Aspira Women's Health Kazia Therapeutics Sol-Gel Technologies PharmaCyte Biotech NLS Pharmaceutics IN8bio Avalo Therapeutics CERo Therapeutics Trinity Biotech Biora Therapeutics Aspira Women's Health (NASDAQ:AWH) and Ainos (NASDAQ:AIMD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, community ranking, dividends, analyst recommendations, earnings, media sentiment, institutional ownership and profitability. Is AWH or AIMD more profitable? Aspira Women's Health has a net margin of -178.80% compared to Ainos' net margin of -15,348.14%. Aspira Women's Health's return on equity of 0.00% beat Ainos' return on equity.Company Net Margins Return on Equity Return on Assets Aspira Women's Health-178.80% N/A -244.98% Ainos -15,348.14%-64.54%-47.06% Does the MarketBeat Community prefer AWH or AIMD? Aspira Women's Health received 14 more outperform votes than Ainos when rated by MarketBeat users. CompanyUnderperformOutperformAspira Women's HealthOutperform Votes1420.90% Underperform Votes5379.10% AinosN/AN/A Do analysts prefer AWH or AIMD? Aspira Women's Health currently has a consensus price target of $4.40, indicating a potential upside of 405.75%. Given Aspira Women's Health's higher probable upside, equities research analysts clearly believe Aspira Women's Health is more favorable than Ainos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspira Women's Health 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has stronger valuation & earnings, AWH or AIMD? Ainos has lower revenue, but higher earnings than Aspira Women's Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspira Women's Health$8.92M1.57-$16.69M-$1.45-0.60Ainos$120K30.67-$13.77MN/AN/A Does the media refer more to AWH or AIMD? In the previous week, Aspira Women's Health had 4 more articles in the media than Ainos. MarketBeat recorded 4 mentions for Aspira Women's Health and 0 mentions for Ainos. Ainos' average media sentiment score of 0.98 beat Aspira Women's Health's score of 0.00 indicating that Ainos is being referred to more favorably in the news media. Company Overall Sentiment Aspira Women's Health Neutral Ainos Positive Which has more volatility & risk, AWH or AIMD? Aspira Women's Health has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Ainos has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Do insiders and institutionals have more ownership in AWH or AIMD? 12.2% of Aspira Women's Health shares are held by institutional investors. 4.3% of Aspira Women's Health shares are held by insiders. Comparatively, 10.4% of Ainos shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryAspira Women's Health beats Ainos on 9 of the 14 factors compared between the two stocks. Ad Weiss RatingsThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMD vs. The Competition Export to ExcelMetricAinosPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.68M$6.74B$5.02B$8.44BDividend YieldN/A7.94%7.49%4.16%P/E RatioN/A11.61127.0816.62Price / Sales30.67289.441,683.1877.41Price / CashN/A46.0936.9033.53Price / Book0.095.284.585.21Net Income-$13.77M$150.62M$113.81M$223.74M7 Day Performance-16.11%0.30%111.02%2.82%1 Month Performance-7.26%16.75%125.11%8.93%1 Year Performance-84.63%37.44%155.23%29.44% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDAinos1.0962 of 5 stars$0.46+0.5%N/A-84.7%$3.68M$120,000.000.0046Gap DownAWHAspira Women's Health1.1806 of 5 stars$0.90flat$4.40+388.9%-80.9%$14.45M$9.15M-0.62110Upcoming EarningsAnalyst ForecastGap DownKZIAKazia Therapeutics1.6612 of 5 stars$5.52+2.2%$20.00+262.3%+17.7%$14.23M$20,000.000.0012News CoverageGap UpSLGLSol-Gel Technologies2.4441 of 5 stars$0.51+4.1%$5.00+880.2%-61.4%$14.21M$1.55M-0.9450Gap UpPMCBPharmaCyte Biotech0.6715 of 5 stars$1.83+1.1%N/A-17.9%$14.05MN/A2.772Gap DownNLSPNLS Pharmaceutics0.2238 of 5 stars$3.60-0.8%N/A+462.3%$13.75MN/A0.006News CoverageGap UpINABIN8bio3.4069 of 5 stars$0.29+3.6%$10.00+3,391.6%-72.5%$13.40MN/A-0.3520AVTXAvalo Therapeutics1.9756 of 5 stars$12.97-0.3%N/A-47.7%$13.35M$1.92M0.0040Positive NewsCEROCERo TherapeuticsN/A$0.08flatN/AN/A$12.90MN/A0.008Gap DownTRIBTrinity Biotech0.4615 of 5 stars$1.69-4.0%N/A-26.4%$12.88M$56.83M-0.63480Gap DownBIORBiora Therapeutics3.2905 of 5 stars$3.35-2.3%$150.00+4,378.4%-82.3%$12.61MN/A-0.06120Upcoming Earnings Related Companies and Tools Related Companies AWH Competitors KZIA Competitors SLGL Competitors PMCB Competitors NLSP Competitors INAB Competitors AVTX Competitors CERO Competitors TRIB Competitors BIOR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AIMD) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
